Differential role for host translation factors in host and viral protein synthesis during human cytomegalovirus infection

Journal of Virology

Volumn 88, Issue 3, 2014, Pages 1473-1483

  Lenarcic, Erik M ^a   Ziehr, Ben ^a   De Leon, Gabe ^b,c   Mitchell, Duane ^b,c   Moorman, Nathaniel J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INITIATION FACTOR 4F; VIRUS MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE COURSE; GENETIC ASSOCIATION; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; NONHUMAN; POLYSOME; POPULATION ABUNDANCE; PRIORITY JOURNAL; PROTEIN ACTIVITY; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN SYNTHESIS; RNA TRANSLATION; SKIN FIBROBLAST; VIRUS REPLICATION;

CELL LINE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; EUKARYOTIC INITIATION FACTOR-4F; GENE EXPRESSION REGULATION, VIRAL; HUMANS; POLYRIBOSOMES; PROTEIN BIOSYNTHESIS; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84892454259     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02321-13     Document Type: Article

References (46)

1. Brown-Luedi ML, Meyer LJ, Milburn SC, Yau PM, Corbett S, Hershey JW. 1982. Protein synthesis initiation factors from human HeLa cells and rabbit reticulocytes are similar: comparison of protein structure, activities, and immunochemical properties. Biochemistry 21:4202-4206. http://dx .doi.org/10.1021/bi00261a002.
2. Gingras AC, Raught B, Sonenberg N. 1999. eIF4 initiation factors: effec-tors of mRNA recruitment to ribosomes and regulators of translation. Annu. Rev. Biochem. 68:913-963. http://dx.doi.org/10.1146/annurev .biochem.68.1.913.
3. Grifo JA, Tahara SM, Morgan MA, Shatkin AJ, Merrick WC. 1983. New initiation factor activity required for globin mRNA translation. J. Biol. Chem. 258:5804-5810.
4. Muthukrishnan S, Both GW, Furuichi Y, Shatkin AJ. 1975. 5'-Terminal 7-methylguanosine in eukaryotic mRNA is required for translation. Nature 255:33-37. http://dx.doi.org/10.1038/255033a0.
5. Jackson RJ, Hellen CU, Pestova TV. 2010. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat. Rev. Mol. Cell. Biol. 11:113-127. http://dx.doi.org/10.1038/nrm2838.
6. Sonenberg N, Rupprecht KM, Hecht SM, Shatkin AJ. 1979. Eukaryotic mRNA cap binding protein: purification by affinity chromatography on Sepharose-coupled m7GDP. Proc. Natl. Acad. Sci. U.S.A. 76:4345-4349. http://dx.doi.org/10.1073/pnas.76.9.4345.
7. Grifo JA, Tahara SM, Leis JP, Morgan MA, Shatkin AJ, Merrick WC. 1982. Characterization of eukaryotic initiation factor 4A, a protein involved in ATP-dependent binding of globin mRNA. J. Biol. Chem. 257: 5246-5252.
8. Rozen F, Edery I, Meerovitch K, Dever TE, Merrick WC, Sonenberg N. 1990. Bidirectional RNA helicase activity of eucaryotic translation initiation factors 4A and 4F. Mol. Cell. Biol. 10:1134-1144.
9. Bieleski L, Talbot SJ. 2001. Kaposi's sarcoma-associated herpesvirus vCyclin open reading frame contains an internal ribosome entry site. J. Virol. 75:1864-1869. http://dx.doi.org/10.1128/JVI.75.4.1864-1869.2001.
10. Grainger L, Cicchini L, Rak M, Petrucelli A, Fitzgerald KD, Semler BL, Goodrum F. 2010. Stress-inducible alternative translation initiation of human cytomegalovirus latency protein pUL138. J. Virol. 84:9472-9486. http://dx.doi.org/10.1128/JVI.00855-10.
11. Grundhoff A, Ganem D. 2001. Mechanisms governing expression of the v-FLIP gene of Kaposi's sarcoma-associated herpesvirus. J. Virol. 75: 1857-1863. http://dx.doi.org/10.1128/JVI.75.4.1857-1863.2001.
12. Nishimura K, Ueda K, Guwanan E, Sakakibara S, Do E, Osaki E, Yada K, Okuno T, Yamanishi K. 2004. A posttranscriptional regulator of Kaposi's sarcoma-associated herpesvirus interacts with RNA-binding protein PCBP1 and controls gene expression through the IRES. Virology 325:364-378. http://dx.doi.org/10.1016/j.virol.2004.04.041.
13. Walsh D, Perez C, Notary J, Mohr I. 2005. Regulation of the translation initiation factor eIF4F by multiple mechanisms in human cytomegalovirus-infected cells. J. Virol. 79:8057-8064. http://dx.doi.org/10.1128/JVI .79.13.8057-8064.2005.
14. Kudchodkar SB, Yu Y, Maguire TG, Alwine JC. 2004. Human cytomegalovirus infection induces rapamycin-insensitive phosphorylation of downstream effectors of mTOR kinase. J. Virol. 78:11030-11039. http://dx.doi.org/10.1128/JVI.78.20.11030-11039.2004.
15. Moorman NJ, Cristea IM, Terhune SS, Rout MP, Chait BT, Shenk T. 2008. Human cytomegalovirus protein UL38 inhibits host cell stress responses by antagonizing the tuberous sclerosis protein complex. Cell Host Microbe 3:253-262. http://dx.doi.org/10.1016/j.chom.2008.03.002.
16. Moorman NJ, Shenk T. 2010. Rapamycin-resistant mTORC1 kinase activity is required for herpesvirus replication. J. Virol. 84:5260-5269. http://dx.doi.org/10.1128/JVI.02733-09.
17. Gingras AC, Gygi SP, Raught B, Polakiewicz RD, Abraham RT, Hoekstra MF, Aebersold R, Sonenberg N. 1999. Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes Dev. 13:1422-1437. http://dx.doi.org/10.1101/gad.13.11.1422.
18. Gingras AC, Raught B, Sonenberg N. 2001. Regulation of translation initiation by FRAP/mTOR. Genes Dev. 15:807-826. http://dx.doi.org/10 .1101/gad.887201.
19. Clippinger AJ, Maguire TG, Alwine JC. 2011. The changing role of mTOR kinase in the maintenance of protein synthesis during human cytomegalovirus infection. J. Virol. 85:3930-3939. http://dx.doi.org/10 .1128/JVI.01913-10.
20. Spencer CM, Schafer XL, Moorman NJ, Munger J. 2011. Human cytomegalovirus induces the activity and expression of acetyl-coenzyme A carboxylase, a fatty acid biosynthetic enzyme whose inhibition attenuates viral replication. J. Virol. 85:5814-5824. http://dx.doi.org/10.1128/JVI .02630-10.
21. Wang D, Bresnahan W, Shenk T. 2004. Human cytomegalovirus encodes a highly specific RANTES decoy receptor. Proc. Natl. Acad. Sci. U.S.A. 101:16642-16647. http://dx.doi.org/10.1073/pnas.0407233101.
22. Bordeleau ME, Mori A, Oberer M, Lindqvist L, Chard LS, Higa T, Belsham GJ, Wagner G, Tanaka J, Pelletier J. 2006. Functional characterization of IRESes by an inhibitor of theRNAhelicase eIF4A. Nat. Chem. Biol. 2:213-220. http://dx.doi.org/10.1038/nchembio776.
23. Mitchell DP, Savaryn JP, Moorman NJ, Shenk T, Terhune SS. 2009. Human cytomegalovirus UL28 and UL29 open reading frames encode a spliced mRNA and stimulate accumulation of immediate-early RNAs. J. Virol. 83:10187-10197. http://dx.doi.org/10.1128/JVI.00396-09.
24. Cristea IM, Moorman NJ, Terhune SS, Cuevas CD, O'Keefe ES, Rout MP, Chait BT, Shenk T. 2010. Human cytomegalovirus pUL83 stimulates activity of the viral immediate-early promoter through its interaction with the cellular IFI16 protein. J. Virol. 84:7803-7814. http://dx.doi.org/10.1128/JVI.00139-10.
25. Lindqvist L, Oberer M, Reibarkh M, Cencic R, Bordeleau ME, Vogt E, Marintchev A, Tanaka J, Fagotto F, Altmann M, Wagner G, Pelletier J. 2008. Selective pharmacological targeting of a DEAD box RNA helicase. PLoS One 3:e1583. http://dx.doi.org/10.1371/journal.pone.0001583.
26. Thoreen CC, Kang SA, Chang JW, Liu Q, Zhang J, Gao Y, Reichling LJ, Sim T, Sabatini DM, Gray NS. 2009. An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J. Biol. Chem. 284:8023-8032. http://dx.doi.org/10.1074/jbc .M900301200.
27. Hsieh AC, Liu Y, Edlind MP, Ingolia NT, Janes MR, Sher A, Shi EY, Stumpf CR, Christensen C, Bonham MJ, Wang S, Ren P, Martin M, Jessen K, Feldman ME, Weissman JS, Shokat KM, Rommel C, Ruggero D. 2012. The translational landscape of mTOR signaling steers cancer initiation and metastasis. Nature 485:55-61. http://dx.doi.org/10.1038/nature10912.
28. Thoreen CC, Chantranupong L, Keys HR, Wang T, Gray NS, Sabatini DM. 2012. A unifying model for mTORC1-mediated regulation ofmRNA translation. Nature 485:109-113. http://dx.doi.org/10.1038/nature11083.
29. Arnstein HR, Cox RA, Gould H, Potter H. 1965. A comparison of methods for the isolation and fractionation of reticulocyte ribosomes. Biochem. J. 96:500-506.
30. Svitkin YV, Pause A, Haghighat A, Pyronnet S, Witherell G, Belsham GJ, Sonenberg N. 2001. The requirement for eukaryotic initiation factor 4A (elF4A) in translation is in direct proportion to the degree of mRNA 5' secondary structure. RNA 7:382-394. http://dx.doi.org/10.1017/S135583820100108X.
31. Perez C, McKinney C, Chulunbaatar U, Mohr I. 2011. Translational control of the abundance of cytoplasmic poly(A) binding protein in human cytomegalovirus-infected cells. J. Virol. 85:156-164. http://dx.doi .org/10.1128/JVI.01778-10.
32. Pari GS. 2008. Nuts and bolts of human cytomegalovirus lytic DNA replication. Curr. Top. Microbiol. Immunol. 325:153-166. http://dx.doi.org/10.1007/978-3-540-77349-8_9.
33. Chambers JW, Maguire TG, Alwine JC. 2010. Glutamine metabolism is essential for human cytomegalovirus infection. J. Virol. 84:1867-1873. http://dx.doi.org/10.1128/JVI.02123-09.
34. McArdle J, Moorman NJ, Munger J. 2012. HCMV targets the metabolic stress response through activation of AMPK whose activity is important for viral replication. PLoS Pathog. 8:e1002502. http://dx.doi.org/10.1371/journal.ppat.1002502.
35. Munger J, Bajad SU, Coller HA, Shenk T, Rabinowitz JD. 2006. Dynamics of the cellular metabolome during human cytomegalovirus infection. PLoS Pathog. 2:e132. http://dx.doi.org/10.1371/journal.ppat .0020132.
36. Munger J, Bennett BD, Parikh A, Feng XJ, McArdle J, Rabitz HA, Shenk T, Rabinowitz JD. 2008. Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat. Biotechnol. 26: 1179-1186. http://dx.doi.org/10.1038/nbt.1500.
37. Umate P, Tuteja R, Tuteja N. 2010. Genome-wide analysis of helicase gene family from rice and Arabidopsis: a comparison with yeast and human. Plant Mol. Biol. 73:449-465. http://dx.doi.org/10.1007/s11103-010-9632-5.
38. Walsh D, Mohr I. 2006. Assembly of an active translation initiation factor complex by a viral protein. Genes Dev. 20:461-472. http://dx.doi.org/10 .1101/gad.1375006.
39. Aoyagi M, Gaspar M, Shenk TE. 2010. Human cytomegalovirus UL69 protein facilitates translation by associating with the mRNA cap-binding complex and excluding 4EBP1. Proc. Natl. Acad. Sci. U.S.A. 107:2640-2645. http://dx.doi.org/10.1073/pnas.0914856107.
40. Kahvejian A, Roy G, Sonenberg N. 2001. The mRNA closed-loop model: the function of PABP and PABP-interacting proteins in mRNA transla-tion. Cold Spring Harbor Symp. Quant. Biol. 66:293-300. http://dx.doi .org/10.1101/sqb.2001.66.293.
41. McKinney C, Perez C, Mohr I. 2012. Poly(A) binding protein abundance regulates eukaryotic translation initiation factor 4F assembly in human cytomegalovirus-infected cells. Proc. Natl. Acad. Sci. U.S.A. 109:5627-5632. http://dx.doi.org/10.1073/pnas.1202829109.
42. Walsh D, MohrI. 2011. Viral subversion of the host protein synthesis machinery. Nat. Rev. Microbiol. 9:860-875. http://dx.doi.org/10.1038/nrmicro2655.
43. Fitzgerald KD, Semler BL. 2009. Bridging IRES elements in mRNAs to the eukaryotic translation apparatus. Biochim. Biophys. Acta 1789:518-528. http://dx.doi.org/10.1016/j.bbagrm.2009.07.004.
44. Maquat LE, Hwang J, Sato H, Tang Y. 2010. CBP80-promoted mRNP rearrangements during the pioneer round of translation, nonsensemediatedmRNAdecay, and thereafter. Cold Spring Harbor Symp. Quant. Biol. 75:127-134. http://dx.doi.org/10.1101/sqb.2010.75.028.
45. Chiu SY, Lejeune F, Ranganathan AC, Maquat LE. 2004. The pioneer translation initiation complex is functionally distinct from but structurally overlaps with the steady-state translation initiation complex. Genes Dev. 18:745-754. http://dx.doi.org/10.1101/gad.1170204.
46. Panganiban AT, Mir MA. 2009. Bunyavirus N: eIF4F surrogate and cap-guardian. Cell Cycle 8:1332-1337. http://dx.doi.org/10.4161/cc.8 .9.8315.